Young TSPC-Derived Exosomal circPVT1 Ameliorates Aging-Impaired Cell Function via SIRT1/NF-κB

Weifeng Han1, Dongqiang Gu2, Xiaoya Li2

  • 1Department of Orthopaedics, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Insights

Young exosomes from modified tendon stem cells can reverse aging in aged cells. This discovery offers potential therapeutic strategies for age-related tendon diseases and enhances regenerative medicine approaches.

Area of Science:

  • Regenerative Medicine
  • Cellular Senescence
  • Biomolecular Signaling

Background:

  • Tendon stem/progenitor cell (TSPC) senescence contributes to age-related tendon diseases, impairing repair and regeneration.
  • Exosomes, vesicles carrying bioactive molecules, are promising tools in regenerative medicine.

Purpose of the Study:

  • To investigate the antiaging effects of exosomes derived from circPVT1-overexpressing TSPCs (circPVT1-exo) on aged TSPCs.
  • To elucidate the underlying molecular mechanisms of circPVT1-exo in ameliorating TSPC aging.

Main Methods:

  • Isolation and characterization of circPVT1-exo from early-passage TSPCs.
  • Treatment of late-passage TSPCs (L-TSPCs) with circPVT1-exo.
  • Assessment of TSPC self-renewal, proliferation, senescence, tenogenic, and osteogenic capacities.
  • Investigation of the SIRT1/NF-κB signaling pathway.

Main Results:

  • circPVT1-exo attenuated L-TSPC senescence, enhancing self-renewal, proliferation, and tenogenic capacity while suppressing osteogenic differentiation.
  • circPVT1-exo inhibited the NF-κB pathway and upregulated SIRT1 expression in L-TSPCs.
  • SIRT1 knockdown reversed the beneficial effects of circPVT1-exo, confirming its crucial role.

Conclusions:

  • circPVT1-exo demonstrates significant antiaging effects on aged TSPCs.
  • The therapeutic potential of circPVT1-exo in age-related tendon diseases is linked to its modulation of the SIRT1/NF-κB pathway.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.2K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K